Top List: Access your free cancer and immunology resources ahead of the virtual summit
Explore topics from live-cell analysis,
in situ hybridization, cancer therapeutics, cell imaging, and much more
17 May 2021
To help you prepare for the upcoming SelectScience
® Virtual Cancer and Immunology Research Summit launching on Tuesday, May 11, we ve pulled together a selection of the latest resources, methods, and interviews that are progressing the fields of cancer and immunology research, covering topics from next-generation cancer treatments to
in situ hybridization and live-cell imaging.
Next-generation cancer treatment
Watch this video to find out why biomarkers are not only providing novel insights into the biology of cancer but ultimately enabling a new level of patient stratification. This allows the most effective treatment to be used for any given cancer leading to significantly improved outcomes for patients.
Now in its second year, the Virtual Cancer and Immunology Research Summit will cover major new developments in cancer and immunology research, from cutting-edge technologies to novel techniques and top resources to advance your work.
Register free now to watch talks by an outstanding lineup of world-class speakers and leading manufacturers, join live Q&As and dedicated networking sessions, explore virtual resource hubs and discover the latest product launches and application news for your area of expertise.
Among those invited to present will be Dr. Chris Halbrook, assistant professor at the University of California, Irvine (UCI), who highlights the significance of the event: I view this Summit as a great forum to share the research advances of my group with an audience of wide-ranging interests. Much of the success I have had in my career has come through collaborative efforts, and I certainly expect this Summit to lead to some exciting new ideas and interactions.
Discover the scientists advancing cancer research on The Scientists Channel
Hear from cancer research experts such as Dr. Aleksandra Dukic and Dr. Gerhard Bauer on The Scientists Channel
Limiting glioblastoma invasion in the brain: Dr. Aleksandra Dukic, postdoctoral researcher at the Institute for Cancer Research, Oslo University Hospital, discusses how she is investigating novel gap junction inhibitors for use in sensitizing glioblastoma cells to chemotherapy.
The incubation technology accelerating CAR-T cell therapy development: Dr. Gerhard Bauer, Professor of Hematology and Oncology and Director of the GMP lab at the UC Davis Institute, reveals the secrets to success in his work on the production of CAR-T cells.
Editorial Article: Find out how metabolomics-based approaches are revealing tumor microenvironment secrets
Dr. Chris Halbrook discusses how his team are exploring new methods to combat pancreatic cancer
17 Mar 2021
Dr. Chris Halbrook, assistant professor in the Department of Molecular Biology and Biochemistry at University of California, Irvine (UCI)
Improving cancer survival rates is the ultimate goal for all oncologists, especially for those focusing on pancreatic cancer research. With mortality rates ranging from 5-10% within the first five years of diagnosis, early diagnosis and novel therapies are paramount for the future treatment and management of this disease.
In this article, we speak with Dr. Chris Halbrook, assistant professor in the Department of Molecular Biology and Biochemistry at University of California, Irvine (UCI) and speaker at the SelectScience